Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03913559
Title Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital

B-cell adult acute lymphocytic leukemia

childhood B-cell acute lymphoblastic leukemia


Inotuzumab ozogamicin

Cytarabine + Hydrocortisone + Methotrexate

Acetaminophen + Diphenhydramine + Methylprednisolone

Age Groups: child | adult
Covered Countries USA

No variant requirements are available.